Ingevity Corp
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Equity
Index
Note 12: Equity
Accumulated other comprehensive income (loss)
Summarized below is the roll forward of AOCI, net of tax.
| Years Ended December 31, | |||
|---|---|---|---|
| In millions | 2023 | 2022 | 2021 |
| Foreign currency translation | |||
| Beginning balance | $(45.8) | $18.4 | $16.4 |
| Net gains (losses) on foreign currency translation | 20.2 | (74.9) | (5.3) |
| Gains (losses) on net investment hedges | — | 13.9 | 9.6 |
| Less: tax provision (benefit) | — | 3.2 | 2.3 |
| Net gains (losses) on net investment hedges | — | 10.7 | 7.3 |
| Other comprehensive income (loss), net of tax | 20.2 | (64.2) | 2.0 |
| Ending balance | $(25.6) | $(45.8) | $18.4 |
| Derivative instruments | |||
| Beginning balance | $(1.4) | $(2.1) | $(6.9) |
| Gains (losses) on derivative instruments | (4.2) | 11.1 | 7.2 |
| Less: tax provision (benefit) | (1.0) | 2.6 | 1.7 |
| Net gains (losses) on derivative instruments | (3.2) | 8.5 | 5.5 |
| (Gains) losses reclassified to net income | 3.9 | (10.2) | (1.0) |
| Less: tax (provision) benefit | 0.9 | (2.4) | (0.3) |
| Net (gains) losses reclassified to net income | 3.0 | (7.8) | (0.7) |
| Other comprehensive income (loss), net of tax | (0.2) | 0.7 | 4.8 |
| Ending balance | $(1.6) | $(1.4) | $(2.1) |
| Pension and other postretirement benefits | |||
| Beginning balance | $0.4 | $(3.2) | $(4.8) |
| Unrealized actuarial gains (losses) and prior service (costs) credits | 0.1 | 4.4 | 1.9 |
| Less: tax provision (benefit) | — | 1.0 | 0.4 |
| Net actuarial gains (losses) and prior service (costs) credits | 0.1 | 3.4 | 1.5 |
| Amortization of actuarial and other (gains) losses, prior service cost (credits), and settlement and curtailment (income) charge reclassified to net income | 0.1 | 0.3 | 0.2 |
| Less: tax (provision) benefit | 0.1 | 0.1 | 0.1 |
| Net actuarial and other (gains) losses, amortization of prior service cost (credits), and settlement and curtailment (income) charge reclassified to net income | — | 0.2 | 0.1 |
| Other comprehensive income (loss), net of tax | 0.1 | 3.6 | 1.6 |
| Ending balance | $0.5 | $0.4 | $(3.2) |
| Total AOCI ending balance at December 31 | $(26.7) | $(46.8) | $13.1 |
Index
Reclassifications of accumulated other comprehensive income (loss)
The table below provides details about the reclassifications from AOCI and the affected line items on the consolidated statement of operations for each of the periods presented.
| Years Ended December 31, | |||
|---|---|---|---|
| In millions | 2023 | 2022 | 2021 |
| Derivative Instruments | |||
| Currency exchange contracts (1) | $(0.7) | $2.0 | $0.3 |
| Natural gas contracts (2) | (3.2) | 6.5 | 0.7 |
| Interest rate swaps (4) | — | 1.7 | — |
| Total before tax | (3.9) | 10.2 | 1.0 |
| (Provision) benefit for income taxes | 0.9 | (2.4) | (0.3) |
| Amount included within net income (loss) | $(3.0) | $7.8 | $0.7 |
| Pension and other postretirement benefits | |||
| Amortization of prior service credit (costs) (2) | $(0.1) | $(0.1) | $(0.1) |
| Amortization of unrecognized net actuarial and other gains (losses) (3) | — | — | (0.1) |
| Recognized gain (loss) due to curtailment and settlement (2) | — | (0.2) | — |
| Total before tax | (0.1) | (0.3) | (0.2) |
| (Provision) benefit for income taxes | 0.1 | 0.1 | 0.1 |
| Amount included within net income (loss) | $— | $(0.2) | $(0.1) |
(1) Included within "Net sales" on the consolidated statements of operations.
(2) Included within "Cost of sales" on the consolidated statements of operations.
(3) Included within "Other (income) expense, net" on the consolidated statements of operations.
(4) Included within "Interest income" on the consolidated statements of operations.
Share Repurchases
On July 25, 2022, our Board of Directors authorized the repurchase of up to $500.0 million of our common stock (the "2022 Authorization"), and rescinded the prior outstanding repurchase authorization with respect to the shares that remained unused under the prior authorization. Shares under the current repurchase authorization may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market prevailing conditions and other factors, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
During the year ended December 31, 2023, we repurchased $92.1 million (inclusive of $0.8 million in excise tax) in common stock, representing 1,269,373 shares of our common stock at a weighted average cost per share of $71.93. At December 31, 2023, $353.4 million remained unused under our Board-authorized repurchase program. During the year ended December 31, 2022 and 2021, we repurchased $145.2 million and $109.4 million in common stock, representing 2,112,463 and 1,421,379 shares of our common stock at a weighted average cost per share of $68.73 and $76.98, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.